These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2810726)

  • 21. [Clinical evaluation of cefdinir 5% fine granules in pediatrics].
    Iwai N; Nakamura H; Taneda Y; Miyazu M; Kasai K; Watanabe Y
    Jpn J Antibiot; 1991 Oct; 44(10):1096-118. PubMed ID: 1762167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The influence of cefpodoxime proxetil on the intestinal bacterial flora].
    Iwata S; Yamada K; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Nanri S; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1667-84. PubMed ID: 2681865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
    Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
    Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of cefprozil in children].
    Mochizuki Y; Kanazashi S; Hata D; Ohkubo H; Itoh S; Mayumi M; Mikawa H
    Jpn J Antibiot; 1992 Dec; 45(12):1622-34. PubMed ID: 1289580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
    Brown RJ; Batts DH; Hughes GS; Greenwald CA
    Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical evaluation of SY5555 in the treatment of pediatric infections].
    Furukawa S; Okada T
    Jpn J Antibiot; 1995 Feb; 48(2):210-9. PubMed ID: 7745811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.
    Chimura T; Hirayama T; Nakahara M
    Jpn J Antibiot; 1993 Jun; 46(6):482-5. PubMed ID: 8360983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies of cefteram pivoxil in pediatric infection].
    Hirosawa H; Ishikawa Y; Takahashi S; Matsuda H; Ichihashi H
    Jpn J Antibiot; 1989 Aug; 42(8):1828-36. PubMed ID: 2810745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on SY5555 in pediatrics].
    Sekiguchi T; Okamoto T
    Jpn J Antibiot; 1995 Feb; 48(2):220-8. PubMed ID: 7745812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical studies of cefteram pivoxil in pediatrics].
    Iwai N; Nakamura H; Taneda Y; Miyazu M; Kasai K
    Jpn J Antibiot; 1989 Sep; 42(9):1963-80. PubMed ID: 2810758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical observations on cefuzonam in pediatrics].
    Sekiguchi T; Okamoto T; Ohara K; Miyauchi Y; Nishioka A; Kawahito S; Saijo T
    Jpn J Antibiot; 1987 Mar; 40(3):671-9. PubMed ID: 3613086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fundamental and clinical studies on ceftizoxime in pediatric field (author's transl)].
    Iwai N; Taneda Y; Sasaki A; Inokuma K; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Jan; 35(1):47-68. PubMed ID: 6279913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis.
    Mora R; Salami A; Mora F; Cordone MP; Ottoboni S; Passali GC; Barbieri M
    Int J Pediatr Otorhinolaryngol; 2003 Dec; 67 Suppl 1():S225-8. PubMed ID: 14662201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study on cefprozil in pediatrics].
    Iwai N; Miyazu M; Nakamura H; Kasai K
    Jpn J Antibiot; 1992 Nov; 45(11):1537-57. PubMed ID: 1494236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.
    Safran C
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():93-101. PubMed ID: 2292535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experience with ceftizoxime in the pediatric field (author's transl)].
    Hosoda T; Tomimatsu H; Ohara K; Okamoto T
    Jpn J Antibiot; 1982 Jan; 35(1):81-90. PubMed ID: 6279915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.